ABBOTT INDIA
Back to Cashflow Statement
|
ABBOTT INDIA Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1,066 Cr | ₹-925 Cr | ₹-745 Cr | ₹-639 Cr | ₹-637 Cr |
What is the latest Cash Flow from Financing Activities ratio of ABBOTT INDIA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-1,066 Cr |
| Mar2025 | ₹-925 Cr |
| Mar2024 | ₹-745 Cr |
| Mar2023 | ₹-639 Cr |
| Mar2022 | ₹-637 Cr |
How is Cash Flow from Financing Activities of ABBOTT INDIA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-1,066 Cr | Negative | |
| Mar2025 | ₹-925 Cr | Negative | |
| Mar2024 | ₹-745 Cr | Negative | |
| Mar2023 | ₹-639 Cr | Negative | |
| Mar2022 | ₹-637 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹54,335.2 Cr | -4.5% | -1% | -12.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,483.0 Cr | -3.2% | -7.8% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,248.0 Cr | 1% | 0.9% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,822.0 Cr | -1.8% | -4.8% | 32.2% | Stock Analytics | |
| CIPLA | ₹105,427.0 Cr | -3.1% | -6.5% | -12.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,492.3 Cr | -1.7% | 3.1% | -3.5% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | -4.5% |
-1% |
-12.7% |
| SENSEX | -1.2% |
-6.4% |
-10.8% |
You may also like the below Video Courses